ARTICLE | Company News
Avacta, OncoSec combine technologies
January 26, 2018 8:46 PM UTC
Avacta Group plc (LSE:AVCT) and OncoSec Medical Inc. (NASDAQ:ONCS) partnered to combine Avacta’s Affimer protein platform, including its PD-L1 inhibitor AVA04, with OncoSec’s gene delivery technolog...